We Offer Worldwide Shipping
Login Wishlist

D-Galactose

$43

  • Brand : BIOFRON

  • Catalogue Number : BF-D2004

  • Specification : 98%

  • CAS number : 59-23-4

  • Formula : C6H12O6

  • Molecular Weight : 180.16

  • PUBCHEM ID : 6036

  • Volume : 20mg

In stock

Quantity
Checkout Bulk Order?

Catalogue Number

BF-D2004

Analysis Method

HPLC,NMR,MS

Specification

98%

Storage

2-8°C

Molecular Weight

180.16

Appearance

White crystal

Botanical Source

Bupleurum scorzonerifolium

Structure Type

Carbohydrates

Category

Standards;Natural Pytochemical;API

SMILES

C(C1C(C(C(C(O1)O)O)O)O)O

Synonyms

BRAIN SUGAR/4-01-00-04336/galactos/D-(+)-Galactose/Dextrogalactose/(+)-Galactose/D-Galactose (9CI)/Gal/d-galactos/D(+)-Galactose/(+)-aldehydo-D-galactose/Galactose, D-/D(+)-Glactose/aldehydo-D-galactose/Lactoglucose/cerebrose/MaltaseHydrate/Galactose/D-Galactose

IUPAC Name

(3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol

Density

1.6±0.1 g/cm3

Solubility

Water

Flash Point

286.7±26.6 °C

Boiling Point

527.1±50.0 °C at 760 mmHg

Melting Point

168-170 °C(lit.)

InChl

InChl Key

WGK Germany

RID/ADR

HS Code Reference

2940000000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:59-23-4) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

PMID

29808261

Abstract

PURPOSE:
The impact of preoperative functional status on 30-day unplanned postoperative intubation and clinical outcomes among patients who underwent cervical spine surgery is not well-described. We hypothesized that functional dependence is associated with 30-day unplanned postoperative intubation and that among the reintubated cohort, functional dependence is associated with adverse postoperative clinical outcomes after cervical spine surgery.

METHODS:
Utilizing the 2007-2016 American College of Surgeons National Surgical Quality Improvement Program database, we identified adult elective anterior and posterior cervical spine surgery patients by Current Procedural Terminology codes. We performed (1) a Cox Proportional Hazard analysis for the following outcomes: reintubation, prolonged ventilator use, and pneumonia and (2) an adjusted logistic regression analysis among patients that required postoperative reintubation to evaluate the association of functional status with adverse postoperative outcomes.

RESULTS:
The sample size was 26,263, of which 550 (2.1%) were functionally dependent. The adjusted model suggested that when compared with functionally independent patients, dependent patients were at increased risk of unplanned 30-day intubation (HR 2.05, 95% CI 1.26-3.34; P = 0.003). The adjusted risk of 30-day postoperative pneumonia was significantly higher in patients with functional dependence (HR 1.61, 95% CI 1.02-2.54, P = 0.036). Among patients that required postoperative reintubation, the odds of 30-day mortality was significantly higher in patients with functional dependence (OR 5.82, 95% CI 1.59-23.4, P < 0.001).

CONCLUSION:
Preoperative functional dependence is a good marker for estimating postoperative unplanned intubation following cervical spine surgery.

KEYWORDS

Cervical spine surgery; Functional status; Pulmonary complications; Reintubation

Title

Dependent functional status is associated with unplanned postoperative intubation after elective cervical spine surgery: a national registry analysis.

Author

Burton BN1, Lin TC1, A'Court AM1, Schmidt UH1, Gabriel RA2,3.

Publish date

2018 Aug;

PMID

27393442

Abstract

In recent days response surface methodology (RSM) has widely been applied for development and optimization of cost effective formulations with required quality. Study comprised of three steps including micromeritic comparison of different powder blends of placebo and diclofenac potassium (DP), formulation designing with CCRD (Design Expert, version 7.0.0), and stability testing of selected formulations by using R Gui. Ten formulations (F11-F20) were developed using microcrystalline cellulose (Avicel PH-102) (X1) (13-72%), methocel K15M (X2) (6.59-23.4%) and magnesium stearate (X3) (1.32-4.68%), while responses were % friability and % drug release. Blending rate constant was determined at 3, 6, 9 and 12 minutes. The results of physicochemical parameters were found within acceptable limits. After in vitro testing at pH 1.2, pH 4.5 and pH 6.8, mechanism of drug release, kinetic analysis and statistical evaluation were carried out by model – independent, model-dependent and one-way ANOVA methods. Most formulations followed zero order kinetics at higher pH. Fickian release (0.326 ≤ n ≤0.449) was observed with β greater than 0.5 and less than 1. ANOVA indicated no significant variation within and between formulations as p-values were found to be > 0.05

Title

Intermediate release formulations of diclofenac potassium tablets for IVIVC.

Author

Ali H1, Shoaib MH2, Zafar F2, Bushra R, Yasmin R3, Siddiqui S4, Alam ZM2.

Publish date

2016 Jul


Description :

Empty ...